← FDA Drug Approvals (Drugs@FDA)
BREZTRI AEROSPHERE
NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2020-07-23
Drug application
- FDA Application #
NDA212122- Application type
- New Drug Application
- Brand name
- BREZTRI AEROSPHERE
- Generic name
- BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE
- Active ingredients
- BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
- Dosage form
- AEROSOL, METERED
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA AB
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2020-07-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown